Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Owanate Briggs"'
Autor:
Sally D Miller, Greta Lozano-Ortega, Alex Mutebi, Owanate Briggs, Kavita Sail, Brian Elliott, Anupama Kalsekar
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 1 (2022)
Aim: To evaluate trials of systemic therapies in transplant-ineligible or -experienced, relapsed/refractory diffuse large-B cell lymphoma and the impact of patient characteristics on overall response rate (ORR). Patients & methods: Systematically r
Externí odkaz:
https://doaj.org/article/be8020763af24c6a81f85df7e89ac718
Autor:
Sally D, Miller, Greta, Lozano-Ortega, Alex, Mutebi, Owanate, Briggs, Kavita, Sail, Brian, Elliott, Anupama, Kalsekar
Publikováno v:
Journal of Comparative Effectiveness Research. 12
Aim: To evaluate trials of systemic therapies in transplant-ineligible or -experienced, relapsed/refractory diffuse large-B cell lymphoma and the impact of patient characteristics on overall response rate (ORR). Patients & methods: Systematically rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df81f5fa05ed4bc28a52f650aa243c58
https://doi.org/10.2217/cer-2022-0146
https://doi.org/10.2217/cer-2022-0146
Publikováno v:
Substance abuse. 43(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62fcfc0a7b5e5dbb9cc6be900004ba0a
https://pubmed.ncbi.nlm.nih.gov/35426772
https://pubmed.ncbi.nlm.nih.gov/35426772
Autor:
Dominick Latremouille-Viau, Eytan M. Stein, Sherry Shi, George J Joseph, Annie Guerin, Patrick Gagnon-Sanschagrin, Owanate Briggs, Gaetano Bonifacio
Publikováno v:
Journal of Medical Economics. 21:556-563
Objective: To describe the setting, duration, and costs of induction and consolidation chemotherapy for adults with newly-diagnosed acute myeloid leukemia (AML), who are candidates for standard induction chemotherapy, in the US. Methods: Adults newly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::783f5a8801cfd0d04995e542dbe75e41
https://doi.org/10.1080/13696998.2018.1425209
https://doi.org/10.1080/13696998.2018.1425209
Autor:
Johannes E. Wolff, Dominick Latremouille-Viau, Ehab Atallah, Owanate Briggs, Ellen K. Ritchie, Annie Guerin, George J Joseph, Irina Pivneva
Publikováno v:
Journal of Clinical Oncology. 35:7052-7052
7052 Background: This study assessed TKI discontinuation practice in the US before the publication of new practice guidelines in November 2016 including recommendations on TKI discontinuation for patients (pts) with CML in chronic phase (CML-CP). Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1be5c1fa488714b12ded5ae3d756770a
https://doi.org/10.1200/jco.2017.35.15_suppl.7052
https://doi.org/10.1200/jco.2017.35.15_suppl.7052